Press Releases
Ceapro Inc. Presents Encouraging Results from Research Collaboration Study with McMaster University Evaluating PGX-Processed Yeast Beta Glucan for Interstitial Lung Diseases
Ceapro Announces Positive Findings Demonstrating Oat Derived Beta Glucan and Avenanthramides Promote Wound Healing and Tissue Regeneration
Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations
Ceapro Inc. Reports Record 2022 Financial Results and Operational Highlights
Ceapro Announces Data from Research Collaboration with McMaster University to be Presented at the 2023 American Thoracic Society (ATS) International Conference
Ceapro Announces Data from Research Collaboration with the Angiogenesis Foundation to be Presented at the 2023 Annual Meeting of the Wound Healing American Society
Ceapro Inc. Recognized as a Top 50 TSX Venture Exchange Company
Ceapro to Present at the Virtual Investor 2023 Companies to Watch Event
Ceapro Announces Grant of Stock Options
